(Q45862071)

17 December 2017

title

Variation in the immune response to adenoviral vectors in the brain: influence of mouse strain, environmental conditions and priming (English)

1 reference

17 December 2017

1 reference

Ohmoto Y

1

1 reference

17 December 2017

Wood MJ

2

1 reference

17 December 2017

Charlton HM

3

1 reference

17 December 2017

Kajiwara K

4

1 reference

17 December 2017

Perry VH

5

1 reference

17 December 2017

Wood KJ

6

1 reference

17 December 2017

publication date

1 April 1999

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

6

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

471-481

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3300851

exact match

0 references

cites work

Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Immune responses to adenovirus vectors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Immune responses to adenoviral vectors during gene transfer in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Regulation of gene expression by interferons: control of H-2 promoter responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Recombinant human adenovirus with rat MIP-2 gene insertion causes prolonged PMN recruitment to the murine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Adenovirus-mediated gene transfer to the central nervous system for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Second-generation adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

T cell memory. Long-term persistence of virus-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Viruses and T cell turnover: evidence for bystander proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

T cell responses and viral escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Adenovirus gene transfer causes inflammation in the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Transfer of a foreign gene into the brain using adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Interactions of the murine gammaherpesvirus with the immune system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

The immunogenicity of intracerebral virus infection depends on anatomical site.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Murine cytotoxic T-cell response to alphavirus is associated mainly withH- 2D ( k )

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

The immune response of the lacrimal gland to antigenic exposure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3300851

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3300851

1 reference

17 December 2017

Dimensions Publication ID

1035442338

0 references

1 reference

17 December 2017